Theradiag (France) Market Value

ALTHE Stock  EUR 0.34  0.03  8.11%   
Theradiag's market value is the price at which a share of Theradiag trades on a public exchange. It measures the collective expectations of Theradiag SA investors about its performance. Theradiag is selling at 0.34 as of the 26th of November 2024; that is 8.11% down since the beginning of the trading day. The stock's last reported lowest price was 0.34.
With this module, you can estimate the performance of a buy and hold strategy of Theradiag SA and determine expected loss or profit from investing in Theradiag over a given investment horizon. Check out Theradiag Correlation, Theradiag Volatility and Theradiag Alpha and Beta module to complement your research on Theradiag.
Symbol

Please note, there is a significant difference between Theradiag's value and its price as these two are different measures arrived at by different means. Investors typically determine if Theradiag is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theradiag's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Theradiag 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Theradiag's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Theradiag.
0.00
10/27/2024
No Change 0.00  0.0 
In 30 days
11/26/2024
0.00
If you would invest  0.00  in Theradiag on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Theradiag SA or generate 0.0% return on investment in Theradiag over 30 days. Theradiag is related to or competes with Biomerieux, Eurofins Scientific, Sartorius Stedim, and SEB SA. Theraclion SA develops, manufactures, and markets Echopulse ultrasound medical imaging tool for the non-invasive and amb... More

Theradiag Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Theradiag's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Theradiag SA upside and downside potential and time the market with a certain degree of confidence.

Theradiag Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Theradiag's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Theradiag's standard deviation. In reality, there are many statistical measures that can use Theradiag historical prices to predict the future Theradiag's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Theradiag's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.374.84
Details
Intrinsic
Valuation
LowRealHigh
0.020.314.78
Details
Naive
Forecast
LowNextHigh
0.010.364.83
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.320.360.39
Details

Theradiag SA Backtested Returns

Theradiag appears to be out of control, given 3 months investment horizon. Theradiag SA owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0641, which indicates the firm had a 0.0641% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Theradiag SA, which you can use to evaluate the volatility of the company. Please review Theradiag's Risk Adjusted Performance of 0.0792, semi deviation of 2.63, and Coefficient Of Variation of 1080.76 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Theradiag holds a performance score of 5. The entity has a beta of -0.0677, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Theradiag are expected to decrease at a much lower rate. During the bear market, Theradiag is likely to outperform the market. Please check Theradiag's treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether Theradiag's existing price patterns will revert.

Auto-correlation

    
  0.71  

Good predictability

Theradiag SA has good predictability. Overlapping area represents the amount of predictability between Theradiag time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Theradiag SA price movement. The serial correlation of 0.71 indicates that around 71.0% of current Theradiag price fluctuation can be explain by its past prices.
Correlation Coefficient0.71
Spearman Rank Test-0.18
Residual Average0.0
Price Variance0.0

Theradiag SA lagged returns against current returns

Autocorrelation, which is Theradiag stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Theradiag's stock expected returns. We can calculate the autocorrelation of Theradiag returns to help us make a trade decision. For example, suppose you find that Theradiag has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Theradiag regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Theradiag stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Theradiag stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Theradiag stock over time.
   Current vs Lagged Prices   
       Timeline  

Theradiag Lagged Returns

When evaluating Theradiag's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Theradiag stock have on its future price. Theradiag autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Theradiag autocorrelation shows the relationship between Theradiag stock current value and its past values and can show if there is a momentum factor associated with investing in Theradiag SA.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Theradiag Stock Analysis

When running Theradiag's price analysis, check to measure Theradiag's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theradiag is operating at the current time. Most of Theradiag's value examination focuses on studying past and present price action to predict the probability of Theradiag's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theradiag's price. Additionally, you may evaluate how the addition of Theradiag to your portfolios can decrease your overall portfolio volatility.